期刊文献+

Gd+-EOB-DTPA与Gd+-DTPA增强磁共振检查肝细胞癌的对照研究 被引量:12

A compared study on Gd+-EOB-DTPA and Gd+-DTPA-enhanced MRI in detection of hepatocellular carcinoma
原文传递
导出
摘要 目的 比较研究Gd+-EOB-DTPA与Gd+-DTPA两种增强磁共振对比剂对肝细胞癌检查的准确性.方法 21例肝细胞癌患者术前分别进行Gd+-EOB-DTPA与Gd+-DTPA两种增强磁共振检查,以病灶显示质量指数、病灶诊断敏感性、特异性、阳性预测值、阴性预测值、诊断准确率及对比噪声比为指标进行评价,重点比较两种对比剂的差异性.结果 21例肝细胞癌患者共25个病灶,其中<1.0cm病灶9个.Gd+-EOB-DTPA增强磁共振检查肝胆特异期呈低信号有24个病灶,仅1个病灶呈等信号.Gd+-DTPA增强磁共振检查门脉期呈低信号病灶15个、等高信号5个、高信号5个.Gd+-EOB-DTPA及Gd+-DTPA增强磁共振检查对于肝细胞癌(特别是<1.0cm)的病灶显示质量指数,病灶诊断敏感性、特异性、阳性预测值、阴性预测值、诊断正确率分别为17分、89%、89%、89%、89%及12分、33%、33%、33%、67%,肝胆特异期的对比噪声比为:639.35,Gd+-DTPA动脉期及门脉期对比噪声比分别为:225.25及93.25,Gd+-EOB-DTPA均优于Gd+-DTPA增强磁共振检查.结论 采用Gd+-EOB-DTPA对比剂能较Gd+-DTPA对比剂更好地显示肝小病灶,可明显提高微小肝细胞癌(<1.0 cm)诊断正确率. Objective To evaluate the diiterence of image quality and lesion detection between Gd*-EOB-DTPA with Gd+-DTPA-enhanced MRI in cases of hepatocellular carcinoma (HCC). Methods A total of 21 HCC patients underwent both Gd^-EOB-DTPA and Gd-DTPA-enhanced MRI examination, comparing the difference between the two agents using the value of lesion display quality index, sensitivity, specificity, positive and negative predictive value, diagnosis accuracy and CNR. Results There were 25 lesions on the 21 HCC patients with 9 lesions 〈 1.0 cm. 24 lesions showed hypointensity and 1 lesion showed isointensity on hepatobiliary phase with Gd ~ -EOB-DTPA-enhanced MRI. 15 lesions showed hypoimensily, 5 lesions showed isointensity and 5 lesions showed hyperintensity on portal venous phase with Gd ~ -DTPA-enhanced MRI. The value of lesion ( in particular for the lesion 〈 1.0 cm) display quality index, sensitivity, specificity, positive and negative predictive value, diagnosis accuracy on Gd +-EOB-DTPA-enhanced MRI and Gd ^-DTPA-enhanced MRI were 17scors, 89% , 89%, 89% , 89% and 12 scors, 33%, 33%, 33%, 67% respectively. CNR on hepatobiliary phase with Gd+-EOB-DTPA- enhanced MRI was 639.35. CNR on arterial phase and portal venous phase with Gd ~ -DTPA-enhanced MRI were 225.25 and 93.25 respectively. The data showed that Gd +-EOB-DTPA-enhanced MRI was better than that of Gd+-DTPA-enhanced MRI. Conclusions Gd^-EOB-DTPA-enhanced MRI displays lesions (especially for lesions 〈 1.0 cm) better compared with Gd ~ -DTPA-enhanced MRI increasing the diagnostic accuracy of small HCC.
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第9期682-685,共4页 Chinese Journal of General Surgery
基金 上海市科委2012年医学引导类科技基金资助项目(124119a3100)
关键词 肝细胞 磁共振成像 对比噪声比 Carcinoma, hepatoce|lular Magnatic resonance imaging Contrast noise ratio
  • 相关文献

参考文献10

  • 1Kudo M. Muhistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol, 2009, 44 ( Suppl 19 ) : 112-118.
  • 2Seale MK, Catalano OA, Saini S, et al. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. RadioGraphics, 2009, 29: 1725-1748.
  • 3Ahn SS, Kim M J, Lira JS, et all. Added value of gadoxetic acid enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology, 2010, 255: 459466.
  • 4李仕来,黎乐群,彭涛,苏铭.多结节多中心性肝细胞肝癌的临床病理特征及预后[J].中华普通外科杂志,2010,25(10):792-796. 被引量:4
  • 5Iehikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase , rnultieenter comparison between gadoxetic acid disodium- enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol, 2010, 45 : 133-141.
  • 6Kim YK, Kim CS, Han YM, et al. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic imaging versus multi-detector row computed tomography. J Comput Assist Tomogr, 2009, 33: 844-850.
  • 7Bluemke DA, Sahani D,Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U. S. multicenter phase UI study. Radiology, 2005, 237: 89-98.
  • 8Ramm SS, Leafy C,Bluemke DA, et al. hnproved characterization of focal liver lesions with liver-specific gadoxetic acid disodium- enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr, 2010, 34: 163-172.
  • 9Narita M, Hatano E, Arizono S, et al. Expression of OATP1 B3 determines uptake of Gd-EOB-DTPA in hepatocellulm" carcinoma. J Gastroenterol, 2009, 44:793-798.
  • 10Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma : correlation with histological grading and portal blood flow. Eur Radiol, 2010, 20: 2405-2513.

二级参考文献13

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 2Okuda K,Peters PL,Simson IW.Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas:proposal of new classification.Cancer,1984,54:2165-2173.
  • 3Calabrese P,TavaréS,Shibata D.Pretumor progression:clonal evolution of human stem cell populations.Am J Pathol,2004,164:1337-1346.
  • 4Koike K.Hepatitis B virus X gene is implicated in liver carcinogenesis.Cancer Lett,2009,286:60-68.
  • 5Ikeda K,Arase Y,Kobayashi M,et al.Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma:a long term cohort study of 892 patients with viral cirrhosis.J Gastroenterol,2003,38:865-876.
  • 6Shimada M,Hamatsu T,Yamashita Y,et al.Characteristics of multicentric hepatocellular carcinoma:comparison with intrahepatic metastasis.World J Surg,2001,25:991-995.
  • 7Nakano S,Haratake J,Okamoto K,et al.Investigation of resected multinodular hepatocellular carcinoma:assessment of unicentric or multicentric genesis from histological and prognostic viewpoint.Am J Gastroenterol,1994,89:189-193.
  • 8Poon RTP,Fan ST,Wong J.Risk factors,prevention,and management of postoperative recurrence after resection of hepatocellular carcinoma.Ann Surg,2000,232:10-24.
  • 9Arii S,Yamaoka Y,Fatagawa S,et al.Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma:a retrospective and nationwide survey in Japan.Hepatology,2000,32:1224-1229.
  • 10Maeda T,Takenaka K,Taguchi K,et al.Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.Hepatogastroenterology,2000,47:498-503.

共引文献3

同被引文献107

引证文献12

二级引证文献542

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部